Phase 2a randomized controlled trial of short-term activity, safety, and pharmacokinetics of a novel nonnucleoside reverse transcriptase inhibitor, RDEA806, in HIV-1-positive, antiretroviral-naive subjects (Q42006361)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2a randomized controlled trial of short-term activity, safety, and pharmacokinetics of a novel nonnucleoside reverse transcriptase inhibitor, RDEA806, in HIV-1-positive, antiretroviral-naive subjects |
scientific article |
Statements
1 reference
Phase 2a randomized controlled trial of short-term activity, safety, and pharmacokinetics of a novel nonnucleoside reverse transcriptase inhibitor, RDEA806, in HIV-1-positive, antiretroviral-naive subjects (English)
1 reference
Marta Boffito
1 reference
Graeme Moyle
1 reference
Albrecht Stoehr
1 reference
Armin Rieger
1 reference
Zancong Shen
1 reference
Kimberly Manhard
1 reference
Beth Sheedy
1 reference
Vijay Hingorani
1 reference
Anneke Raney
1 reference
Mai Nguyen
1 reference
Tranh Nguyen
1 reference
Voon Ong
1 reference
Li-Tain Yeh
1 reference
Barry Quart
1 reference
24 May 2010
1 reference
1 reference
3170-3178
1 reference
Identifiers
1 reference
1 reference
1 reference